Atlas Trials

Autologous Tumour Vaccine Trial

Clinical trial NCT05807035 · RECRUITING

Trial details

NCT number
NCT05807035
Sponsor
Vaxine Pty Ltd
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2023-02-10
Primary completion
2026-02-10
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.